A group of scientists who have been working on alternative methods in the treatment of chronic diseases since 1990 founded Rejuline® Company in Italy in 2015. The Rejuline® model is the fruit of their efforts. In the Rejuline® model, biological processes in the cells of living organs are analyzed with a different approach. As a result of this approach, new methods have emerged to improve cell functions. In the Rejuline® model, it is assumed that a living cell has a consciousness and mind that controls all reactions and functions of itself, living organs and the body. Although the hypothesis has been put forward by different scientists all over the world, there is no product on the market that can affect cell wisdom. Rejuline® develops new products for chronic diseases, taking cell wisdom into account.